United States Congratulates Madagascar on Arrival of First COVID-19 Vaccines from COVAX

Press Release Shim

Speeches Shim

250,000 doses of the Covishield COVID-19 vaccine arrived on May 8.
250,000 doses of the Covishield COVID-19 vaccine arrived on May 8.
Photo: USAID / A.G. Klei

For Immediate Release

Monday, May 10, 2021

ANTANANARIVO – The United States congratulates Madagascar on the successful arrival of 250,000 doses of the Covishield COVID-19 vaccine on May 8. This shipment was made possible through the COVAX Advance Market Commitment, a global initiative to support equitable access to COVID-19 vaccines. The United States recently announced an initial $2 billion obligation—out of a total planned $4 billion— to Gavi, the Vaccine Alliance, to support the COVAX Advance Market Commitment, making us the single largest contributor to global COVID-19 vaccine access.

“I want to congratulate the Government of Madagascar for taking action to participate in COVAX and bring much needed vaccines to the Malagasy people,” U.S. Ambassador Michael Pelletier said. “The United States is proud to be the largest contributor to COVAX, helping to ensure the equitable delivery of safe and effective vaccines in Madagascar and around the globe.”
 
The COVID-19 pandemic has demonstrated that an infectious disease outbreak anywhere is a threat to people everywhere. It is a global problem that requires a global solution, and we are committed to collaborating with partners and governments to support global COVID-19 vaccination efforts.
 
The U.S. contributions to COVAX, through the U.S. Agency for International Development (USAID), will support the purchase and delivery of safe and effective COVID-19 vaccines for the world’s most vulnerable and at-risk populations in 92 low- and middle-income countries. This support is critical to controlling the pandemic, slowing the emergence of new variants, and helping to restart the global economy. The United States will also continue to work with international donors to build further support for the COVAX Facility’s critical needs.
 
Throughout the pandemic, the United States has worked closely with the Government of Madagascar like “mpirahalahy mianala” to protect public health and strengthen the response to COVID-19. The United States has provided $2.5 million in emergency funding to  support the Government of Madagascar’s COVID-19 response and repurposed $2.2 million worth of USAID health projects to respond to the coronavirus pandemic. This COVID response is just a part of U.S. government’s engagement in Madagascar’s health sector, where we are the largest single-country donor. In 2020 alone, the U.S. government provided $72 million to fund USAID’s health activities in Madagascar.
“The United States is proud to be the largest contributor to COVAX, helping to ensure the equitable delivery of safe and effective vaccines in Madagascar and around the globe.” - U.S. Ambassador Michael Pelletier
“The United States is proud to be the largest contributor to COVAX, helping to ensure the equitable delivery of safe and effective vaccines in Madagascar and around the globe.” - U.S. Ambassador Michael Pelletier
Photo: USAID / A.G. Klei

Last updated: July 26, 2021

Share This Page